You are here: Industry Insights > medicines

News List

It’s time to be more vigilant and quality conscious expresspharma
June 23, 2020
Dr Ashok Omray, Advisor Pharma Operations, Ex AVP, USV and Ex-President, ICPL shares how crucial it is to ensure that quality standards are met and sustained in the pharma industry despite any challenges or crisis faced.
Combating COVID-19 with global standards expresspharma
June 08, 2020
S Swaminathan, COO, GS1 India outlines why adoption of global standards within supply chains of drugs and PPE is critical to ensure their availability to the right patient, at the right place and right time.
NPPA issues draft guidelines to tackle cases of discontinuation of scheduled formulations expresspharma
June 04, 2020
The National Pharmaceutical Pricing Authority (NPPA) has issued draft guidelines for dealing with cases of discontinuation of scheduled formulations under para 21 (2) of DPCO 2013.
State Drug Controllers asked to help pharmaceutical firms in augmenting production of medicines expresspharma
April 26, 2020
Secretary, DOP appreciated the efforts of all SDC’s and requested them to provide all support to manufacturing units with the help of local administration and concerned authorities by regular interaction so that there is no shortage of medicines and medic
India's MoHFW seeks export ban of anti-TB drugs expresspharma
April 22, 2020
Delay in production and receipt of supply may cause an acute shortage of these drugs, highlights Union Health Secretary.
Pharmacists to maintain common flu, symptoms medicines record expresspharma
April 22, 2020
The step is taken to keep tabs on patients/ persons having influenza-like fever, cold, throat infection, flu and similar symptoms who may be affected with COVID-19 but have eluded testing.
EMA task force established to co-ordinate rapid regulatory action for COVID-19 medicines europeanpharmaceuticalreview
April 15, 2020
The COVID-19 EMA pandemic Task Force (COVID-ETF) will aid in the development, authorisation and safety monitoring of COVID-19 vaccines and therapeutics.
Will the industry sell COVID-19 meds at the min production costs? expresspharma
April 15, 2020
Will the pharma industry come through? Can the pharma industry resist pressures from investors and shareholders and sacrifice profits this time?
Engaging with authorities to address challenges regarding manufacturing, distribution of drugs: OPPI expresspharma
April 07, 2020
OPPI continues to remain engaged with the relevant authorities to ensure that these challenges are overcome at the earliest, he added.
Committee for Medicinal Products for Human Use (CHMP) meeting highlights europeanpharmaceuticalreview
March 31, 2020
A summary of the CHMP meeting conclusions, including medicines recommended for approval and indication extension and several safety review findings.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page